Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2019-05-10 Regulatory Filings
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Initiation of a Multi-Centre Trial in China
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated May 10, 2019. It announces a specific corporate event: the 'Initiation of a Multi-Centre Trial of EarlyCDT®-Lung in China'. This is a specific operational update, not a comprehensive financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). The presence of the RNS Number and the nature of the announcement (a specific business development) strongly suggest it is a general regulatory announcement disseminated via the London Stock Exchange's news service. Since it is a specific operational update that doesn't fit perfectly into the other specialized categories (like CAP, LTR, or TAR), the most appropriate classification is the general regulatory announcement category, RNS.
2019-05-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly identified by the 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership thresholds. The definition for 'Major Shareholding Notification' is code MRQ. Although RNS is present, MRQ is a more specific classification for this type of regulatory filing concerning share ownership changes.
2019-04-17 English
Agreement for Portugal and Spain
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content announces a new distribution agreement and an extension of an existing agreement, which is a material business update. Since this is a general announcement of a business event (distribution agreement) and is explicitly marked as an RNS release, it fits best under the general Regulatory Filings category (RNS), as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, SHA, DIRS). Given the explicit RNS header and the nature of the announcement, RNS is the most appropriate classification.
2019-04-05 English
Appointment of Parag Mallick to Scientific Board
Board/Management Information Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content announces the appointment of a new member, Dr. Parag Mallick, to the company's Scientific Board. This type of announcement—a change in key personnel (specifically a board appointment, though not strictly senior management/executive)—falls under the category of general corporate governance or management updates. Since the definitions include 'Board/Management Information' (MANG) for changes in the board of directors or senior management, this is the most appropriate fit. It is not a formal financial report (10-K, IR, ER) or a shareholder vote result (DVA). It is a specific corporate event announcement.
2019-04-02 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly contains the header 'RNS Number : 7470U' and is titled 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2019-04-01 English
EarlyCDT®-Lung Registered in Columbia
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated April 1, 2019. The content announces that Oncimmune's distributor in Columbia has obtained regulatory approval for the sale of EarlyCDT®-Lung. This is a specific, material announcement made via the Regulatory News Service (RNS) system of the London Stock Exchange. Since it is a specific regulatory announcement that doesn't fit into categories like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER), and it is clearly disseminated through the RNS channel, the most appropriate classification is Regulatory Filings (RNS). It is not a full report (like 10-K or IR) but a short news item about a business development.
2019-04-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.